Regeneron Pharmaceuticals(REGN)

2 Best Pharma Stocks to Buy Right Now

Manali Bhade | Feb 23, 2021

These under-appreciated pharma stocks have the potential to become long-term winners.

---

Should You Follow Cathie Wood Into This Coronavirus Stock?

Adria Cimino | Feb 23, 2021

This latest pick has been sluggish so far -- but the long-term opportunity may be huge.

---

1 Big COVID-19 Story That Has Nothing to Do With Vaccines

Keith Speights | Feb 14, 2021

But this development could be enormously important in fighting COVID-19.

---

Can Coronavirus Antibodies Overcome Their Obstacles?

Brian Orelli, PhD and Keith Speights | Feb 12, 2021

Issues with timing, delivery, and manufacturing make the treatments less promising.

---

Regeneron Pharmaceuticals Inc (REGN) Q4 2020 Earnings Call Transcript

Motley Fool Transcribers | Feb 5, 2021

REGN earnings call for the period ending December 31, 2020.

---

What's Behind Regeneron's Stellar Q4 Update

Keith Speights | Feb 5, 2021

The big biotech was firing on all cylinders, and getting strong growth out of its top-selling products.

---

Can Eli Lilly and Regeneron Antibody Treatments Beat New COVID Strains?

Adria Cimino | Jan 29, 2021

There's some good news and some bad news.

---

Could This Drug Be 100% Effective in Preventing Symptomatic COVID-19 Infections?

Jim Crumly | Jan 28, 2021

Strong interim trial data boosts the prospects for a treatment already worth billions.

---

2 Best Pharma Stocks to Buy Right Now

Zhiyuan Sun | Jan 27, 2021

Investors will want to scoop up shares of this diversified drugmaker and coronavirus vaccine developer before it's too late.

---

Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?

Zhiyuan Sun | Jan 14, 2021

This high-growing, blue-chip biotech has just what it takes to make investors rich.

---

Regeneron Stock Rose on COVID-19 Breakthrough

Mac Greer | Mar 19, 2020

Regeneron Pharmaceuticals stock got a shot in the arm after it announced a possible drug candidate for coronavirus.

---

Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018

Motley Fool Staff | Dec 18, 2018

Key trials suggest doctors may change how they treat patients with cardiovascular disease.

---

3 Top Stocks After #ASH18

Todd Campbell | Dec 6, 2018

Positive trial data unveiled at the American Society of Hematology conference makes these top stocks to watch in 2019.

---

Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?

Todd Campbell | Aug 17, 2017

With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players.

---

Here's Why Intellia Therapeutics Gained as Much as 18.0% Today

Maxx Chatsko | Jun 1, 2020

An existing partner is doubling down on the gene editing platform.

---

Why Regeneron Pharmaceuticals Shares Rose 10% in March?

Anne Burdakin | Apr 8, 2020

The company that created a successful Ebola treatment takes aim at COVID-19.

---

Why Regeneron Pharmaceuticals Stock Is Bolting Higher Today

George Budwell | Mar 17, 2020

The biotech announces that it is working on an antibody cocktail to be used against COVID-19.

---

Why Regeneron Shares Rose 31.6% in February

Adria Cimino | Mar 5, 2020

Regeneron’s work on a coronavirus treatment gave the stock a lift.

---

Here's Why Regeneron Pharmaceuticals Tumbled 12% in May

Brian Orelli, PhD | Jun 10, 2019

Sales growth is slowing, and there's an issue with one of the biotech's pipeline drugs.

---

Here's What Weighed on Regeneron Pharmaceuticals Inc. in February

Cory Renauer | Mar 6, 2018

Investors worried about a potential hit to Eylea's revenues down the road drove the stock lower.

---

This Double Whammy Caused Regeneron Pharmaceuticals Inc. to Fall 10% in November

Sean Williams | Dec 6, 2017

Shareholders aren't seeing too clearly after this double-dose of news concerning lead drug Eylea.

---

Here's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October

Cory Renauer | Nov 7, 2017

Tiny start-up AnaptysBio helped spread fear that Dupixent's ongoing commercial launch might fizzle out.

---

Why Regeneron Pharmaceuticals Dropped 11.3% in September

Brian Feroldi | Oct 5, 2017

The release of phase 3 trial results that failed to impress led to a sinking share price.

---

What's Behind Regeneron's Big 15% Bounce in May?

Todd Campbell | Jun 2, 2017

Launching two new drugs this year has sparked optimism that Regeneron Pharmaceuticals is on the upswing.

---

Regeneron Pharmaceuticals Inc (REGN) Q4 2020 Earnings Call Transcript

Motley Fool Transcribers | Feb 5, 2021

REGN earnings call for the period ending December 31, 2020.

---

Regeneron Pharmaceuticals (REGN) Q1 2020 Earnings Call Transcript

Motley Fool Transcribing | May 5, 2020

REGN earnings call for the period ending March 31, 2020.

---

Regeneron Pharmaceuticals (REGN) Q4 2019 Earnings Call Transcript

Motley Fool Transcribing | Feb 6, 2020

REGN earnings call for the period ending December 31, 2019.

---

Regeneron Pharmaceuticals (REGN) Q3 2019 Earnings Call Transcript

Motley Fool Transcribing | Nov 5, 2019

REGN earnings call for the period ending September 30, 2019.

---

Regeneron Pharmaceuticals (REGN) Q2 2019 Earnings Call Transcript

Motley Fool Transcribing | Aug 6, 2019

REGN earnings call for the period ending June 30, 2019.

---

Regeneron Pharmaceuticals (REGN) Q1 2019 Earnings Call Transcript

Motley Fool Transcribing | May 7, 2019

REGN earnings call for the period ending March 31, 2019.

---

Regeneron Pharmaceuticals Inc (REGN) Q4 2018 Earnings Conference Call Transcript

Motley Fool Transcribers | Feb 6, 2019

REGN earnings call for the period ending December 31, 2018.

---

Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript

Motley Fool Transcribers | Nov 6, 2018

REGN earnings call for the period ending September 30, 2018.

---